| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8454786 | Lung Cancer | 2016 | 4 Pages |
Abstract
We herein report the first case of histological neuroendocrine transformation after ALK inhibitor crizotinib treatment, associated with acquired resistance to crizotinib.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Charline Caumont, Rémi Veillon, Audrey Gros, Elodie Laharanne, Hugues Bégueret, Jean-Philippe Merlio,